Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology EL Clayton, S Mizielinska, JR Edgar, TT Nielsen, S Marshall, FE Norona, ... Acta neuropathologica 130, 511-523, 2015 | 96 | 2015 |
Synaptic tau: A pathological or physiological phenomenon? M Robbins, E Clayton, GS Kaminski Schierle Acta Neuropathologica Communications 9, 1-30, 2021 | 50 | 2021 |
Microelectrode arrays for simultaneous electrophysiology and advanced optical microscopy S Middya, VF Curto, A Fernández‐Villegas, M Robbins, J Gurke, ... Advanced Science 8 (13), 2004434, 2021 | 43 | 2021 |
Amygdala dopamine receptors are required for the destabilization of a reconsolidating appetitive memory E Merlo, P Ratano, EC Ilioi, MALS Robbins, BJ Everitt, AL Milton eneuro 2 (1), 2015 | 32 | 2015 |
OptiJ: Open-source optical projection tomography of large organ samples PP Vallejo Ramirez, J Zammit, O Vanderpoorten, F Riche, FX Blé, ... Scientific reports 9 (1), 15693, 2019 | 27 | 2019 |
Calcium imaging analysis–how far have we come? M Robbins, CN Christensen, CF Kaminski, M Zlatic F1000Research 10, 2021 | 20 | 2021 |
Therapies for Tau-associated neurodegenerative disorders: targeting molecules, synapses, and cells M Robbins Neural Regeneration Research 18 (12), 2633-2637, 2023 | 6 | 2023 |
Biofunctionalised bacterial cellulose scaffold supports the patterning and expansion of human embryonic stem cell-derived dopaminergic progenitor cells M Robbins, V Pisupati, R Azzarelli, SI Nehme, RA Barker, L Fruk, ... Stem Cell Research & Therapy 12, 1-12, 2021 | 6 | 2021 |
Synaptopathy in CHMP2B frontotemporal dementia highlights the synaptic vesicle cycle as a therapeutic target M Robbins, EL Clayton Neural Regeneration Research 18 (2), 315-316, 2023 | 2 | 2023 |
OptoGenie: an open-source device for the optogenetic stimulation of cells M Robbins, O Siddiqui, T Fuchsberger, G Goodfellow, O Paulsen, ... Journal of Open Hardware 5 (1), 2, 2021 | 1 | 2021 |
Machine learning-based spike sorting reveals how subneuronal concentrations of monomeric Tau cause a loss in excitatory postsynaptic currents in hippocampal neurons M Brockhoff, J Träuble, S Middya, T Fuchsberger, A Fernandez-Villegas, ... bioRxiv, 2024.02. 29.582792, 2024 | | 2024 |
Tau 相关神经退行性疾病的治疗: 靶向分子, 突触和细胞 M Robbins 中国神经再生研究 (英文版) 18 (12), 2633, 2023 | | 2023 |
CHMP2B 额颞叶痴呆的突触病变突出突触小泡周期作为治疗靶点 M Robbins, EL Clayton 中国神经再生研究 (英文版) 18 (2), 315, 2023 | | 2023 |
UNDERSTANDING THE PATHOLOGICAL EFFECTS OF EXOGENOUS MONOMERIC TAU PROTEIN AND THE DEVELOPMENT OF NOVEL TREATMENTS FOR ALZHEIMER’S DISEASE M Robbins | | 2020 |
Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology. EL Clayton, S Mizielinska, JR Edgar, TT Nielsen, S Marshall, FE Norona, ... JOURNAL OF NEUROCHEMISTRY 138, 335-335, 2016 | | 2016 |